Identification of small molecule ErbB4 agonists for treatment of heart failure.
Activating the neuregulin-1/ErbB4 pathway for treatment of heart failure.
Studies of the ErbB4 receptor in myocardial non-myocytes to create new opportunities for the treatment of cardiac disease.
Effect of iron status and red cell indices on exercise capacity and response of exercise training
Diagnostic and therapeutic potential of microRNA-181c in HFpEF.
Publication type
|
|
|
|
|